This new 291-page report from Venture Planning Group provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2014 Strategies for the European Therapeutic Drug Monitoring (TDM) Market: Hospitals, Commercial Labs, Physician Offices, Ambulatory Care Centers is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 291 pages and 61 tables
SIMILAR MARKET STUDIES
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies. The report provides test volume and sales forecasts; compares features of major ...
October 2016 | $0 | View Details >>
About This ReportThis new 322-page report from VPGMarketResearch.com presents detailed analysis of the Italian Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition ...
July 2015 | $1450 | View Details >>
Complete report $1,850. DataPack (test volumes, sales forecasts, supplier shares) $1,200. The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. This new study from VPGMarketResearch contains 407 pages, and is designed to help current suppliers and potential market entrants identify and ...
November 2015 | $1200 | View Details >>
Asia-Pacific Electrophysiology Procedures Outlook to 2021 Summary GlobalDataï¿½s new report, "Asia-Pacific Electrophysiology Procedures Outlook to 2021", provides key procedures data on the Asia-Pacific Electrophysiology Procedures. The report provides procedure volumes within market segment - Electrophysiology Ablation Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based ...
April 2016 | $3995 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research